Cargando…
Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B
OBJECTIVE: To explore the effect of ginkgo biloba extract (EGb) as an adjunctive treatment of elderly patients with depression and the effect on the expression of serum S100B. METHODS: 136 elderly patients with depression were divided into EGb + citalopram (Cit) group and Cit group equally. Efficac...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181482/ https://www.ncbi.nlm.nih.gov/pubmed/30278520 http://dx.doi.org/10.1097/MD.0000000000012421 |
_version_ | 1783362408296742912 |
---|---|
author | Dai, Chun-Xiao Hu, Chang-Chun Shang, Yu-Shan Xie, Jian |
author_facet | Dai, Chun-Xiao Hu, Chang-Chun Shang, Yu-Shan Xie, Jian |
author_sort | Dai, Chun-Xiao |
collection | PubMed |
description | OBJECTIVE: To explore the effect of ginkgo biloba extract (EGb) as an adjunctive treatment of elderly patients with depression and the effect on the expression of serum S100B. METHODS: 136 elderly patients with depression were divided into EGb + citalopram (Cit) group and Cit group equally. Efficacy was evaluated by Hamilton Depression Rating Scale (HAMD). Wisconsin Card Classification Test (WCST) was used to evaluate cognitive function. Serum S100B expression was measured with ELISA. The relationship of S100B with HAMD, Hamilton Anxiety Scale (HAMA) score, and WCST results was evaluated subsequently. RESULTS: The time of onset of efficacy was significantly shorter in EGb + Cit group. There were significant differences in HAMD and HAMA scores after treatment than before treatment between groups (all P < .05). After treatment, total number of WCST test, the number of continuous errors and non-persistent errors in both groups were less than those before treatment. The correct number and classifications number were increased than before treatment. In EGb + Cit group, correct numbers and classifications were increased, and the number of persistent errors was decreased. After treatment, S100B level was decreased, and S100B levels change in EGb + Cit group was greater than in Cit group. Serum S100B level was positively correlated with HAMD and HAMA scores before treatment and positively correlated with persistent errors number in WCST. CONCLUSION: EGb, as an adjunctive treatment, can effectively improve depressive symptoms and reduce expression of serum S100B, which is a marker of brain injury, suggesting that EGb restores neurologic function during the treatment of depression in elderly patients and S100B participates in the therapeutic mechanism. EGb combined with depressive drugs plays synergistic role, and the time of onset of efficacy is faster than single antidepressants. |
format | Online Article Text |
id | pubmed-6181482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-61814822018-10-15 Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B Dai, Chun-Xiao Hu, Chang-Chun Shang, Yu-Shan Xie, Jian Medicine (Baltimore) Research Article OBJECTIVE: To explore the effect of ginkgo biloba extract (EGb) as an adjunctive treatment of elderly patients with depression and the effect on the expression of serum S100B. METHODS: 136 elderly patients with depression were divided into EGb + citalopram (Cit) group and Cit group equally. Efficacy was evaluated by Hamilton Depression Rating Scale (HAMD). Wisconsin Card Classification Test (WCST) was used to evaluate cognitive function. Serum S100B expression was measured with ELISA. The relationship of S100B with HAMD, Hamilton Anxiety Scale (HAMA) score, and WCST results was evaluated subsequently. RESULTS: The time of onset of efficacy was significantly shorter in EGb + Cit group. There were significant differences in HAMD and HAMA scores after treatment than before treatment between groups (all P < .05). After treatment, total number of WCST test, the number of continuous errors and non-persistent errors in both groups were less than those before treatment. The correct number and classifications number were increased than before treatment. In EGb + Cit group, correct numbers and classifications were increased, and the number of persistent errors was decreased. After treatment, S100B level was decreased, and S100B levels change in EGb + Cit group was greater than in Cit group. Serum S100B level was positively correlated with HAMD and HAMA scores before treatment and positively correlated with persistent errors number in WCST. CONCLUSION: EGb, as an adjunctive treatment, can effectively improve depressive symptoms and reduce expression of serum S100B, which is a marker of brain injury, suggesting that EGb restores neurologic function during the treatment of depression in elderly patients and S100B participates in the therapeutic mechanism. EGb combined with depressive drugs plays synergistic role, and the time of onset of efficacy is faster than single antidepressants. Wolters Kluwer Health 2018-09-28 /pmc/articles/PMC6181482/ /pubmed/30278520 http://dx.doi.org/10.1097/MD.0000000000012421 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Research Article Dai, Chun-Xiao Hu, Chang-Chun Shang, Yu-Shan Xie, Jian Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B |
title | Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B |
title_full | Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B |
title_fullStr | Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B |
title_full_unstemmed | Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B |
title_short | Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B |
title_sort | role of ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum s100b |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181482/ https://www.ncbi.nlm.nih.gov/pubmed/30278520 http://dx.doi.org/10.1097/MD.0000000000012421 |
work_keys_str_mv | AT daichunxiao roleofginkgobilobaextractasanadjunctivetreatmentofelderlypatientswithdepressionandontheexpressionofserums100b AT huchangchun roleofginkgobilobaextractasanadjunctivetreatmentofelderlypatientswithdepressionandontheexpressionofserums100b AT shangyushan roleofginkgobilobaextractasanadjunctivetreatmentofelderlypatientswithdepressionandontheexpressionofserums100b AT xiejian roleofginkgobilobaextractasanadjunctivetreatmentofelderlypatientswithdepressionandontheexpressionofserums100b |